Complement dysregulation during the early phases of synucleinopathy - Top-Institutions - MDSpire

Alterations in Complement System Function During the Initial Stages of Synucleinopathy

  • By

  • Hina Khan

  • Mary Gifford

  • Arash Kordbacheh

  • Asher Bury

  • Spencer Panoushek

  • Allyson Cole-Strauss

  • Christopher J. Kemp

  • Kelvin C. Luk

  • Kathy Steece-Collier

  • Nathan C. Kuhn

  • Nicholas M. Kanaan

  • Caryl E. Sortwell

  • Joseph R. Patterson

  • Matthew J. Benskey

  • July 20, 2026

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Michigan State University Grand Rapids Research Center
    Michigan State University Grand Rapids Research Center

    Grand Rapids, Michigan

    Key Differentiators

    • Neurology

  • #2

    Michigan Brain Bank
    Michigan Brain Bank

    Ann Arbor, Michigan

    Key Differentiators

    • Neurology

  • #3

    University of Colorado School of Medicine
    University of Colorado School of Medicine

    Aurora, Colorado

    Key Differentiators

    • Neurology

  • #4

    Sydney Brain Bank
    Sydney Brain Bank

    Sydney, New South Wales

    Key Differentiators

    • Neurology

  • #5

    University of New South Wales
    University of New South Wales

    Sydney, New South Wales

    Key Differentiators

    • Neurology

Original Source(s)

Complement dysregulation during the early phases of synucleinopathy

  • by Hina Khan, Mary Gifford, Arash Kordbacheh, Asher Bury, Spencer Panoushek, Allyson Cole-Strauss, Christopher J. Kemp, Kelvin C. Luk, Kathy Steece-Collier, Nathan C. Kuhn, Nicholas M. Kanaan, Caryl E. Sortwell, Joseph R. Patterson, Matthew J. Benskey

  • July 20, 2026

Related Content

Remimazolam versus propofol on seizure adequacy in electroconvulsive therapy: a retrospective cohort study

EEGDecoder-x: an explainable deep learning framework for cross-subject EEG-based detection of Alzheimer's and Creutzfeldt–Jakob disease

Single-cell analysis reveals KLF10-high macrophages induced by glioblastoma cells are associated with tumor progression